ClinConnect ClinConnect Logo
Search / Trial NCT06776354

AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods

Launched by ZHEN WANG · Jan 9, 2025

Trial Information

Current as of July 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Graduate or regulatory trainee, currently rotating in cardiology and willing to participate in research.
  • Age between 18-30 years old, gender not limited.
  • No specialized training experience in hypertension diagnosis and treatment, only possessing basic medical theoretical knowledge.
  • Able to accept a 4-week teaching intervention (2 hours of study per week).
  • Sign the informed consent form and be aware of the research purpose and process.
  • Exclusion Criteria:
  • Graduate students or trained interns who have received specialized training in hypertension medication treatment.
  • Students unable to complete the full course of study (e.g., rotations shorter than four weeks or potential mid-course withdrawal).
  • Unable to consistently participate in educational interventions (e.g., conflicts with study schedule).
  • Have severe physical or mental health issues that may affect the learning process.
  • Have language comprehension barriers or cognitive impairments, making it difficult to complete learning tasks.

About Zhen Wang

Zhen Wang is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a commitment to ethical practices and regulatory compliance, Zhen Wang collaborates with leading researchers and healthcare professionals to design and implement rigorous clinical studies. The organization emphasizes transparency, data integrity, and patient safety, ensuring that all trials are conducted with the highest standards of quality. By fostering partnerships and leveraging cutting-edge technologies, Zhen Wang aims to accelerate the development of effective treatments across various therapeutic areas.

Locations

Hefei, Anhui, China

Patients applied

0 patients applied

Trial Officials

xianrui luo

Study Chair

The Second Hospital of Anhui Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported